Pionyr Immunotherapeutics
Monte Montgomery is currently the Chief Financial Officer at Pionyr Immunotherapeutics. Prior to this role, Monte held various finance and accounting positions at companies such as Relypsa, KAI Pharmaceuticals, Exelixis, Inc., and InterMune, Inc. Monte also has experience as a Supervising Senior Auditor at Ernst & Young. Monte graduated from UC Santa Barbara with a Bachelor of Art in Business Economics.
This person is not in any offices
Pionyr Immunotherapeutics
Pionyr Immunotherapeutics discovers and develops first-in-class biologic drugs that fine-tune natural immune responses to increase immune defenses for diseases such as cancer, or to dampen immune responses in autoimmune diseases.